VirtualScopics Inc

VirtualScopics — FY2014 Earnings Presentation

13 slides from VirtualScopics's earnings presentation, Feb 27, 2015

  1. Slide 1: Fourth Quarter & Full Year 2014 Performance Review

    500 Linden Oaks, 2 nd Floor Rochester, New York 14625 (585) 249 - 6231 www.virtualscopics.com NASDAQ: VSCP Fourth Quarter & Full Year 2014 Performance Review February 26, 2015 1

  2. Slide 2: Forward-looking statements

    The statements contained in this press release that are not purely historical are forward - looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe h

  3. Slide 3: Awards Outstanding, Bookings and Book to Bill

    2OIAVActivity/ Assessment ayo ES i (millions of dollars) As of December 31, 2014 2013 Change Awards Outstanding $ 22 $ 34 (35%) Bookings $ 262 $17.1 53% Awards Outstanding and Bookings $ 284 $205 39% Three Months Ended Twelve Months Ended December 31, December 31, 20142013 Change 20142013 Change Boo

  4. Slide 4: Income statement: revenues, gross profit and operating loss

    4 2014 2013 Change 2014 2013 Change Revenues 2,710$ 2,707$ 0% 10,452$ 11,174$ -6% Cost of Services 1,975$ 1,660$ 19% 7,091$ 6,755$ 5.0% Gross Profit 735$ 1,047$ -30% 3,361$ 4,419$ -24% Gross Margin 27% 39% 32% 40% Operating Expenses Research and Development 346$ 331$ 5% 1,245$ 1,511$ -18% Sales and

  5. Slide 5: December 31, 2014 Balance Sheet

    December 3i)2014)BalancelSheet | December 31, | December 31, 2014 2013 (Unaudited) Assets Current assets Cash $ 4,046,599 $ 7,330,630 Accounts receivable. net 1,814,143 1,725,070 Prepaid expenses and other current assets 410,188 397,699 Total current assets 6,270,930 9,453,399 Patents, net 1,211,770

  6. Slide 6: $26.2 Million in Bookings

    • $26.2 Million in Bookings is GREAT News! • Bookings are Something We Can Control - Operational Excellence - Business Development Efforts • Backlog – All Bookings are Added to Backlog 6

  7. Slide 7: Revenue is a Function of Backlog

    • Revenue is a Function of Backlog • Number of Images Received Controls Revenue – Large delivery of images – higher revenue – Small delivery of images – lower revenue • Larger Backlog Helps to Better Predict Revenue – More Projects to balance high and low deliveries 7

  8. Slide 8: Retained all Top Pharma Customers

    • Higher Phase III studies • Retained all Top Pharma Customers – Added three New Wins from Top Pharma • Program Award • Focus on Oncology, MSK and Cardiac – 2013 > 50% Non Core Services – 2014 > 90% Core Services 8

  9. Slide 9: We do Imaging for Clinical Trials

    • We do Imaging for Clinical Trials!! – FDA Audit – No Findings! • No Distractions – Personalized Medicine has been Tabled • Market is Growing – R&D Spend Expected to Grow – Outsourcing to Continue • Citi Report – “Listen to the Little Guy: Citi’s CRO Survey Suggests Market Trends Will Remain Favora

  10. Slide 10: Short Term and Long Term Revenue

    • Short Term Revenue – Deliver Quality Work – Defend Bookings • Long Term Revenue – Deliver Quality Work – Business Development Communicates • Deliver Quality Projects • On Time • Within Budget • On a Consistent Basis! 10

  11. Slide 11: Maintain Operational Excellence

    • Maintain Operational Excellence – Defend Short Term Revenue • Continue to Build Backlog – Reduce Difficulty in Predicting Revenue • Invest in Efficiency Technologies • Improve Share Price • Stay in This Market! 11

  12. Slide 12: Two New Board Members

    • Two New Board Members – Andrew Levitch – Financial Strategy – Michael Woehler – DIRECT Industry Experience • Investor Conferences • Better Marketing Communications • Further Alliance Development • Scientific Advisory Board – Key Opinion Leaders 12

  13. Slide 13: Your feedback is always appreciated!

    Your feedback is always appreciated! 13

VirtualScopics — FY2014 Earnings Presentation on 6ix